Skip to main content

Diagnostic options · UAE

Microbiology tests in Dubai & UAE

Compare available Microbiology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

299

Listed price range

490.00–5,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Microbiology test prices

Showing 46–60 of 299 matching tests.

Microbiology diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-967
Choclo Virus Viral Load Quantitative Test

This diagnostic test directly measures the amount of Choclo hantavirus RNA present in a patient's sample, providing a quantitative assessment of viral load.

Serum or Plasma (peripheral blood) Critical result phoned within 24 hours; official report by email within 36 hours 1,200.00 AED
View
View test specifications and preparation
What it measures
["Choclo hantavirus RNA", "Viral Load"]
Parameters
[{"name": "Choclo Virus RNA Viral Load", "reference_range": "Limit of Detection: 10 copies/mL"}]
Preparation
["No specific fasting required", "Continue all prescribed medications unless directed otherwise by physician"]
Indications
["Suspected Choclo virus infection", "Monitoring disease progression in confirmed cases", "Assessing treatment response", "Stratifying disease severity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103903-3 ICD-10: B33.4
Clinical summary
This diagnostic test directly measures the amount of Choclo hantavirus RNA present in a patient's sample, providing a quantitative assessment of viral load.
TEST-105
Clinical Metatranscriptomic Sequencing Analysis Test

This test evaluates the active gene expression profiles of microbes (bacteria, fungi, viruses) and the host within a sample.

Peripheral Whole Blood (PAXgene Blood RNA Tube); Environmental / Clinical Swabs in DNA/RNA Shield 8 Weeks (Complex Bioinformatics) 5,500.00 AED
View
View test specifications and preparation
What it measures
["Active RNA Transcripts", "Host immune pathway expression", "Microbial gene expression"]
Parameters
[]
Preparation
["Abstain from probiotics for 72 hours prior to collection.", "Abstain from digestive enzymes for 72 hours prior to collection.", "Abstain from antimicrobial supplements for 72 hours prior to collection."]
Indications
["Complex infectious disease research", "Oncology research", "Suspected reactive arthritis (rheumatology)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92715-5 ICD-10: B99.9
Clinical summary
This test evaluates the active gene expression profiles of microbes (bacteria, fungi, viruses) and the host within a sample.
TEST-2992
Comprehensive Respiratory Pathogen Panel 5 Test

This diagnostic test evaluates for the presence of five specific respiratory viruses: Influenza A/B, RSV, SARS-CoV-2, Adenovirus, and Human Metapneumovirus.

Oropharyngeal/nasal swab, sputum, or bronchoalveolar lavage (BAL) 48–72 hours from sample receipt 1,500.00 AED
View
View test specifications and preparation
What it measures
["Influenza A/B", "Respiratory Syncytial Virus (RSV)", "SARS-CoV-2", "Adenovirus", "Human Metapneumovirus"]
Parameters
[]
Preparation
[]
Indications
["Suspected viral respiratory infection", "Severe respiratory illness", "Hospital-acquired respiratory infection", "Need for specific pathogen identification for treatment or infection control"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92856-0 ICD-10: J06.9, Z20.8
Clinical summary
This diagnostic test evaluates for the presence of five specific respiratory viruses: Influenza A/B, RSV, SARS-CoV-2, Adenovirus, and Human Metapneumovirus.
TEST-985
Crimean-Congo Hemorrhagic Fever (CCHF) Viral Load Quantitative Test

This test quantifies the amount of Crimean-Congo Hemorrhagic Fever virus RNA in biological samples.

Blood serum, plasma, or cerebrospinal fluid (CSF) Phone 36 hours – Email 4th working day 1,000.00 AED
View
View test specifications and preparation
What it measures
["Crimean-Congo Hemorrhagic Fever virus RNA", "Viral replication activity"]
Parameters
[{"name": "Viral Load", "reference_range": "Reported as copies per mL"}, {"name": "Genotype Information", "reference_range": "Provided via Whole Genome Sequencing analysis"}]
Preparation
["No fasting required", "Sign consent form", "Provide complete clinical history (anticoagulant use, travel, tick bites, occupational exposures)"]
Indications
["High clinical suspicion of CCHF", "Tick exposure", "Contact with livestock in endemic regions", "Travel to endemic regions", "Occupational exposure in healthcare or agricultural settings", "Therapeutic monitoring"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101387-5 ICD-10: A98.0
Clinical summary
This test quantifies the amount of Crimean-Congo Hemorrhagic Fever virus RNA in biological samples.
TEST-1018
Crimean-Congo Hemorrhagic Fever (CCHF) Virus RNA Detection (Qualitative) Test

This test detects the genetic material (RNA) of the Crimean-Congo Hemorrhagic Fever virus in patient samples.

Whole blood, serum, plasma (home collection available); cerebrospinal fluid (CSF) – hospital extraction only Phone: 36 hours / Email: 4 working days 1,200.00 AED
View
View test specifications and preparation
What it measures
["Viral RNA"]
Parameters
[]
Preparation
["Sign consent form", "Provide clinical history"]
Indications
["Suspected CCHF infection", "Exposure to CCHF endemic areas", "Presence of relevant symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94461-6 ICD-10: A98.0
Clinical summary
This test detects the genetic material (RNA) of the Crimean-Congo Hemorrhagic Fever virus in patient samples.
TEST-763
Cryptococcus neoformans Detection PCR Test

This test detects the presence of Cryptococcus neoformans DNA in patient samples.

Whole Blood (EDTA), CSF, Sputum, Other Body Fluids, Tissue 13 Working Days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Cryptococcus neoformans DNA"]
Parameters
[]
Preparation
[]
Indications
["Suspected cryptococcal meningitis", "Suspected pulmonary cryptococcosis", "Suspected disseminated cryptococcosis", "Patients with significant immunosuppression"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49609-6 ICD-10: B45
Clinical summary
This test detects the presence of Cryptococcus neoformans DNA in patient samples.
TEST-945
Cryptococcus Quantitative Test (PCR & WGS)

This test quantifies Cryptococcus DNA in patient samples using PCR and WGS.

Tissue, Blood, Respiratory specimens, Cerebrospinal fluid (CSF) Email: 48 hours, Phone: 36 hours 1,000.00 AED
View
View test specifications and preparation
What it measures
["Cryptococcus neoformans DNA copy number", "C. gattii DNA copy number", "Antifungal resistance markers"]
Parameters
[{"name": "Fungal DNA Load", "reference_range": null}]
Preparation
["No special diet or fasting required"]
Indications
["Suspected cryptococcal infection", "Monitoring response to antifungal therapy", "Diagnosis in immunocompromised patients", "Detection of antifungal resistance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 29580-2 ICD-10: B45.0, B45.1, B45.2, B45.3, B45.7, B45.8, B45.9
Clinical summary
This test quantifies Cryptococcus DNA in patient samples using PCR and WGS.
TEST-932
Cryptococcus RNA Detection Qualitative Test

This test detects the presence of Cryptococcus RNA in clinical samples to diagnose active fungal infection.

Blood, Cerebrospinal Fluid (CSF), Bronchoalveolar Lavage (BAL), Tissue 36–48 hours 700.00 AED
View
View test specifications and preparation
What it measures
["Cryptococcus RNA"]
Parameters
[]
Preparation
["No special preparation or fasting required"]
Indications
["Suspected cryptococcal meningitis", "Suspected disseminated cryptococcosis", "Immunocompromised individuals (HIV/AIDS, organ transplant, chemotherapy) with relevant symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60256-9 ICD-10: B45.9
Clinical summary
This test detects the presence of Cryptococcus RNA in clinical samples to diagnose active fungal infection.
TEST-912
Culture-Based AFB Antitubercular Drug Susceptibility Testing (DST) Rapid 4-Drug Panel Test

This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to four key anti-TB drugs (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide).

Pure culture of Mycobacterium tuberculosis complex 21 days from pure culture receipt 900.00 AED
View
View test specifications and preparation
What it measures
["Susceptibility to Isoniazid (INH)", "Susceptibility to Rifampicin (RIF)", "Susceptibility to Ethambutol (EMB)", "Susceptibility to Pyrazinamide (PZA)"]
Parameters
[{"name": "Isoniazid (INH)", "reference_range": "Susceptible / Resistant"}, {"name": "Rifampicin (RIF)", "reference_range": "Susceptible / Resistant"}, {"name": "Ethambutol (EMB)", "reference_range": "Susceptible / Resistant"}, {"name": "Pyrazinamide (PZA)", "reference_range": "Susceptible / Resistant"}]
Preparation
["No patient preparation required for this test phase.", "A pure culture of Mycobacterium tuberculosis complex must be submitted."]
Indications
["Diagnosis of tuberculosis", "Guidance for anti-tuberculosis treatment", "Detection of drug resistance", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 41683-7 ICD-10: Z01.89
Clinical summary
This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to four key anti-TB drugs (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide).
TEST-882
Cultured AFB Anti-Tubercular Drug Susceptibility Testing (DST) for Isoniazid (INH) Test

This test determines the susceptibility or resistance of Mycobacterium tuberculosis complex to the anti-TB drug isoniazid.

Pure cultured isolate of Mycobacterium tuberculosis complex 21 days from receipt of pure culture 650.00 AED
View
View test specifications and preparation
What it measures
["Susceptibility of Mycobacterium tuberculosis to Isoniazid", "Phenotypic resistance profile"]
Parameters
[]
Preparation
["No direct preparation needed from the patient", "Initial specimen (sputum/respiratory sample) must be collected under medical supervision"]
Indications
["Diagnosis of tuberculosis", "Monitoring treatment response", "Identification of drug resistance patterns"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 28959-4 ICD-10: A15.0, A15.7, Z86.13
Clinical summary
This test determines the susceptibility or resistance of Mycobacterium tuberculosis complex to the anti-TB drug isoniazid.
TEST-873
Cultured AFB Anti-Tubercular DST for Clofazimine Test

This test evaluates the susceptibility of Mycobacterium tuberculosis to the anti-TB drug clofazimine using a phenotypic culture method.

Pure bacterial isolate (from prior sputum or tissue culture) 21 days from pure isolate 700.00 AED
View
View test specifications and preparation
What it measures
["Clofazimine susceptibility", "Mycobacterium tuberculosis growth"]
Parameters
[]
Preparation
["No direct patient preparation required", "Sample is a pure bacterial isolate from prior culture"]
Indications
["Diagnosis of MDR-TB", "Guidance for MDR-TB treatment selection", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 29580-3 ICD-10: A15.0, Z16.39, U82.2
Clinical summary
This test evaluates the susceptibility of Mycobacterium tuberculosis to the anti-TB drug clofazimine using a phenotypic culture method.
TEST-886
Cultured AFB Anti‑Tubercular Drug Susceptibility Testing (DST) for Ofloxacin Test

This diagnostic test evaluates the susceptibility of cultured Mycobacterium tuberculosis isolates to the antibiotic ofloxacin.

Pure Culture Isolate (Mycobacterium tuberculosis) 21 days from pure culture receipt 650.00 AED
View
View test specifications and preparation
What it measures
["Phenotypic susceptibility of Mycobacterium tuberculosis", "Resistance to ofloxacin"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of MDR-TB or pre-XDR-TB", "Guiding treatment regimen selection for TB"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 68545-1 ICD-10: Z11.1
Clinical summary
This diagnostic test evaluates the susceptibility of cultured Mycobacterium tuberculosis isolates to the antibiotic ofloxacin.
TEST-915
Cultured AFB Anti‑Tubercular Drug Susceptibility Testing (Streptomycin) Test

This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to the antibiotic streptomycin using automated fluorometric methods.

Pure bacterial isolate (Mycobacterium tuberculosis complex); sputum or whole blood accepted for in-lab culture processing 21 working days from pure culture 650.00 AED
View
View test specifications and preparation
What it measures
["Minimum Inhibitory Concentration (MIC) of Streptomycin", "Streptomycin Resistance/Susceptibility"]
Parameters
[]
Preparation
["No special patient preparation is required."]
Indications
["Diagnosis of tuberculosis", "Monitoring treatment response", "Guiding therapy for retreatment or severe cases", "Public health surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 29458-0 ICD-10: U84.0, A15.0, Z16.24
Clinical summary
This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to the antibiotic streptomycin using automated fluorometric methods.
TEST-889
Cultured AFB Antitubercular Drug Susceptibility Test

This diagnostic test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the anti-tubercular drug pyrazinamide.

Archival Tissue Specimen – Pure growth isolate of Mycobacterium tuberculosis complex on solid or liquid medium 21 working days from pure growth receipt 800.00 AED
View
View test specifications and preparation
What it measures
["Mycobacterium tuberculosis resistance to pyrazinamide", "Phenotypic growth inhibition"]
Parameters
[{"name": "Pyrazinamide Susceptibility", "reference_range": "Sensitive / Resistant"}]
Preparation
["No specific patient preparation required; sample is a pure culture isolate."]
Indications
["Diagnosis of drug-resistant tuberculosis", "Monitoring treatment response", "Guiding selection of anti-tubercular therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 22334-7 ICD-10: Z16.24, A15.0, Z20.1
Clinical summary
This diagnostic test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the anti-tubercular drug pyrazinamide.
TEST-877
Cultured AFB Antitubercular Drug Susceptibility Testing — Ethionamide (DST) Test

This test determines the susceptibility of Mycobacterium tuberculosis complex isolates to the anti-TB drug ethionamide.

Pure Bacterial Isolates (M. tuberculosis complex culture) 21 Calendar Days 650.00 AED
View
View test specifications and preparation
What it measures
["Mycobacterium tuberculosis complex susceptibility to ethionamide", "Minimum Inhibitory Concentration (MIC)"]
Parameters
[{"name": "Minimum Inhibitory Concentration (MIC)", "reference_range": null}]
Preparation
[]
Indications
["Diagnosis of MDR-TB", "Guidance for second-line anti-TB therapy", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50416-1 ICD-10: Z16.342, A15.0, Z11.1
Clinical summary
This test determines the susceptibility of Mycobacterium tuberculosis complex isolates to the anti-TB drug ethionamide.

Category overview

Microbiology: overview

Uncovering the hidden causes of illness is the essential first step toward targeted treatment and restoring your peace of mind. The Microbiology division at DNA Labs UAE employs advanced automated culturing and antimicrobial susceptibility technologies to identify specific microscopic pathogens accurately. By pinpointing the exact bacteria or fungi involved, our comprehensive microbiology testing in the UAE serves as a vital guide for your doctor’s clinical decision-making. Operating as a premier diagnostic lab in Dubai/UAE, we guarantee the highest standards of data security and strict confidentiality, delivering fast, highly accurate results you can rely on. Take the guesswork out of your recovery. Browse our microbiology diagnostic tests, schedule a convenient home collection, or speak with our laboratory experts today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area